Evidence map›Paper›PMID 33130899›Full record

ArticleNeuro-oncology2021

Functional analysis of low-grade glioma genetic variants predicts key target genes and transcription factors.

Mohith Manjunath, Jialu Yan, Yeoan Youn, Kristen L Drucker, Thomas M Kollmeyer, Andrew M McKinney, Valter Zazubovich, Yi Zhang, Joseph F Costello, Jeanette Eckel-Passow and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Neuro-oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Value of artificial intelligence in neuro-oncology.The Lancet. Digital health · 2025
    Review
  3. Article
  4. Fresh Insights IntoOncology reviews · 2024
    Review
  5. Review
  6. Article
  7. Article
  8. Association of RNA mBioMed research international · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Mohith ManjunathDepartment of Physics, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
Jialu YanDepartment of Physics, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
Yeoan YounCenter for Biophysics and Quantitative Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
Kristen L DruckerDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Thomas M KollmeyerDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Andrew M McKinneyDepartment of Neurological Surgery, University of California San Francisco, San Francisco, California, USA.
Valter ZazubovichDepartment of Physics, Concordia University, Montreal, Québec, Canada.
Yi ZhangCarl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
Joseph F CostelloDepartment of Neurological Surgery, University of California San Francisco, San Francisco, California, USA.
Jeanette Eckel-PassowDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Paul R SelvinDepartment of Physics, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
Robert B JenkinsDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Jun S SongDepartment of Physics, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
University of Illinois Urbana-Champaign · USMayo Clinic · USConcordia University · CADana-Farber Cancer Institute · USMayo Clinic in Florida · USNeurological Surgery · USUniversity of California, San Francisco · US

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI AKHILESH PANDEY · 1985 to 2026
$151.3M
TRAININGU54GM114838 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI HAN, JIAWEI, SINHA, SAURABH · 2014 to 2017
$10.8M
Predicting Transcriptional and Epigenetic Networks in Cancer from Sequencing DataR01CA163336 · NCI · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI Jun S Song · 2012 to 2026
$4.4M
UNDERSTANDING THE INTERACTIONS BETWEEN GERMLINE AND SOMATIC ALTERATIONS in the PATHOGENESIS OF GLIOMASR01CA230712 · NCI · MAYO CLINIC ROCHESTER · PI JENKINS, ROBERT B. · 2018 to 2022
$3.3M
Super-Resolution Microscopy of Neuronal Synapses with Small Quantum Dots and Advanced Imaging ToolsR01NS100019 · NINDS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI CHUNG, HEE JUNG, SELVIN, PAUL R · 2017 to 2025
$3.2M
Signaling Regulation of GABP-Mediated Mutant TERT Promoter Activation in GliomaF31CA243187 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MCKINNEY, ANDREW · 2019 to 2020
$80k
NCI NIH HHS F31 CA243187NCI NIH HHS P30 CA015083NCI NIH HHS R01 CA163336NCI NIH HHS R01 CA230712NIGMS NIH HHS U54 GM114838NINDS NIH HHS R01 NS100019
6 · The paper itself

Abstract

backgroundLarge-scale genome-wide association studies (GWAS) have implicated thousands of germline genetic variants in modulating individuals' risk to various diseases, including cancer. At least 25 risk loci have been identified for low-grade gliomas (LGGs), but their molecular functions remain largely unknown.

methodsWe hypothesized that GWAS loci contain causal single nucleotide polymorphisms (SNPs) that reside in accessible open chromatin regions and modulate the expression of target genes by perturbing the binding affinity of transcription factors (TFs). We performed an integrative analysis of genomic and epigenomic data from The Cancer Genome Atlas and other public repositories to identify candidate causal SNPs within linkage disequilibrium blocks of LGG GWAS loci. We assessed their potential regulatory role via in silico TF binding sequence perturbations, convolutional neural network trained on TF binding data, and simulated annealing-based interpretation methods.

resultsWe built an interactive website (http://education.knoweng.org/alg3/) summarizing the functional footprinting of 280 variants in 25 LGG GWAS regions, providing rich information for further computational and experimental scrutiny. We identified as case studies PHLDB1 and SLC25A26 as candidate target genes of rs12803321 and rs11706832, respectively, and predicted the GWAS variant rs648044 to be the causal SNP modulating ZBTB16, a known tumor suppressor in multiple cancers. We showed that rs648044 likely perturbed the binding affinity of the TF MAFF, as supported by RNA interference and in vitro MAFF binding experiments.

conclusionsThe identified candidate (causal SNP, target gene, TF) triplets and the accompanying resource will help accelerate our understanding of the molecular mechanisms underlying genetic risk factors for gliomas.

Indexed as

Genome-Wide Association StudyGliomaAmino Acid Transport SystemsCalcium-Binding ProteinsGenetic Predisposition to DiseaseHumansIntracellular Signaling Peptides and ProteinsNerve Tissue ProteinsPolymorphism, Single NucleotideTranscription FactorsAmino Acid Transport SystemsCalcium-Binding ProteinsIntracellular Signaling Peptides and ProteinsNerve Tissue ProteinsPHLDB1 protein, humanSLC25A26 protein, humanTranscription Factorsfunctional genomicsgenetic variantsGWASlow-grade glioma

Identifiers

PMID33130899
PMCPMC8041333
OpenAlexW3095696354

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.